Skip to main content
JW LIFESCIENCE CORPORATION logo

JW LIFESCIENCE CORPORATION — Investor Relations & Filings

Ticker · 234080 ISIN · KR7234080000 KO Manufacturing
Open in API
Filings indexed 190 across all filing types
Latest filing 2023-02-28 Proxy Solicitation & In…
Country KR South Korea
Listing KO 234080

About JW LIFESCIENCE CORPORATION

https://www.jw-lifescience.co.kr/lifesc…

JW LIFESCIENCE CORPORATION is a specialized manufacturer focused on the development and production of infusion solutions. The company's product portfolio includes a comprehensive range of intravenous (IV) fluids, from basic solutions to advanced nutrient infusions containing essential components such as amino acids, lipids, proteins, vitamins, and minerals. A key area of innovation is the development of high-value-added products, including multi-chambered infusion solutions. The company operates world-class manufacturing facilities and maintains dedicated research and development centers to support its commitment to producing high-quality medical fluids for patient treatment.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to provide shareholders with information regarding upcoming general meetings (AGM/EGM) and to solicit their votes. It contains details on the meeting agenda (approval of financial statements, election of directors/auditors, remuneration limits) and proxy voting procedures. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2023-02-28 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for JW Life Science. It outlines the date, location, agenda items (financial statement approval, director/auditor appointments, and remuneration limits), and details regarding electronic voting. This document serves as the official solicitation and notification for shareholders to attend or vote at the upcoming meeting, which falls under the Proxy Solicitation & Information Statement category.
2023-02-09 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from JW Life Science regarding the decision to pay a cash dividend. It specifies the dividend amount per share, the total dividend amount, the record date, and the expected date of the general meeting. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2023-02-09 Korean
매출액또는손익구조30%(대규모법인15%)미만변경(자율공시)
Earnings Release Classification · 100% confidence The document is a regulatory filing from JW Life Science regarding a change in sales or profit structure (preliminary earnings). It provides key financial highlights such as revenue, operating profit, and net income for the current and previous fiscal years. Since this is an initial announcement of financial results (key highlights only) and not a full annual report or a transcript, it falls under the Earnings Release category. FY 2022
2023-02-09 Korean
수시공시의무관련사항(공정공시)
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement regarding the company's plan for a cash dividend for the 2022 fiscal year, specifying the dividend amount per share (500 KRW) and the record date. This fits the definition of a dividend announcement.
2022-12-15 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for JW Life Science (제이더블유생명과학) covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial information, business operations, management analysis, and financial statements, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.